ABSTRACT
Purpose. The SEOM Future Plan is aimed at identifying the main challenges, trends and needs of the medical oncology speciality over the next years, including potential oncologist workforce shortages, and proposing recommendations to overcome them. Methods. The estimations of the required medical oncologists workforce are based on an updated Medical Oncologist Register in Spain, Medical Oncology Departments activity data, dedication times and projected cancer incidence. Challenges, needs and future recommendations were drawn from an opinion survey and an advisory board. Results. A shortage of 211 FTE medical oncologist specialists has been established. To maintain an optimal ratio of 158 new cases/FTE, medical oncology workforce should reach 1881 FTE by 2035. Conclusions. Main recommendations to face the growing demand and complexity of oncology services include a yearly growth of 2.5% of medical oncologists workforce until 2035, and development and application of more accurate quality indicators for cancer care and health outcomes measure (AU)
No disponible
Subject(s)
Humans , Male , Female , Medical Oncology , Medical Oncology/organization & administration , Societies, Medical/organization & administration , Societies, Medical/standards , Oncology Service, Hospital/organization & administration , Oncology Service, Hospital/standards , Medical Oncology/ethics , Medical Oncology/standards , Societies, Medical/ethics , SpainABSTRACT
Purpose. The Spanish Society of Medical Oncology (SEOM) has conducted a study on the access to oncologic drugs across the 17 Spanish Regions with the aim of identifying potential heterogeneities and making proposals for eliminating the barriers identified at the different levels. Methods. An Expert Panel made up of medical oncologists designed a survey on certain indications approved for 11 drugs in the approach of breast cancer, melanoma, lung cancer, prostate cancer and support treatment. This survey was sent to 144 National Health System (NHS) hospitals. Results. 77 hospitals answered the survey. The information modules analysed were: scope of the Commission that establishes binding decisions related to drug access; conditions, stages and periods of drug application, approval and administration processes; barriers to accessing drugs. Conclusions. The study shows variability in drug access. The SEOM makes proposals addressed to reducing the differences identified and homogenizing drug access conditions (AU)
No disponible
